http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-873182-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f43b52541bf814b2cd0626e5dabbb02a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 |
| filingDate | 1987-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1988-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-873182-L |
| titleOfInvention | Triazaspirodecanylmethylindolone derivatives |
| abstract | Compounds of the formula <IMAGE> I wherein R1 is hydrogen, lower alkyl or acyl; R2 and R3 independently are lower alkyl, aralkyl or alkenyl or R2 and R3 together form a ring of 5 to 8 carbon atoms; R4 is phenyl, substituted phenyl, cyclohexyl, substituted cyclohexyl, cyclopentyl, substituted cyclopentyl, cycloheptyl, or substituted cycloheptyl; R5 is hydrogen or lower alkyl; R6 is hydrogen, lower alkyl or acyl; and pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I and pharmaceutically acceptable acid addition salts thereof are anti-emetic agents which lack central nervous system side effects.n[US4707484A] |
| priorityDate | 1986-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.